Research and practice progress of graded pharmaceutical care

WU Xianglei; BU Ying; CHEN Xiaohui; BAO Leilei

doi:10.6039/j.issn.1001-0408.2026.19.19

您当前的位置：

首页 >

文章列表页 >

Research and practice progress of graded pharmaceutical care

更新时间：2026-10-12

- Research and practice progress of graded pharmaceutical care
- ZHONGGUO YAOFANG Vol. 37, Issue 19, Pages: 2597-2601(2026)
- 作者机构：
  
  海军军医大学第三附属医院药剂科，上海　200438
- 作者简介：
- 基金信息：
- DOI：10.6039/j.issn.1001-0408.2026.19.19
  CLC： R95
- Received：18 May 2026，
  
  Revised：2026-09-23，
  
  Accepted：24 September 2026，
  
  Published：15 October 2026
- 稿件说明：
移动端阅览
吴相雷,卜莹,陈小慧,等.分级药学监护的研究与实践进展 [J].中国药房,2026,37(19):2597-2601.

WU Xianglei,BU Ying,CHEN Xiaohui,et al.Research and practice progress of graded pharmaceutical care[J].ZHONGGUO YAOFANG,2026,37(19):2597-2601.
吴相雷,卜莹,陈小慧,等.分级药学监护的研究与实践进展 [J].中国药房,2026,37(19):2597-2601. DOI： 10.6039/j.issn.1001-0408.2026.19.19.

WU Xianglei,BU Ying,CHEN Xiaohui,et al.Research and practice progress of graded pharmaceutical care[J].ZHONGGUO YAOFANG,2026,37(19):2597-2601. DOI： 10.6039/j.issn.1001-0408.2026.19.19.

摘要

随着人口老龄化，患者用药复杂程度持续增加，对药学监护的需求逐渐多元化，有限的药学资源难以满足临床需求。分级药学监护通过对患者用药风险进行分层，实现药学资源的差异化配置。本文系统梳理分级药学监护的发展历程和实践进展，分析其发展挑战并提出建议。结果显示，分级药学监护历经概念提出、工具研发与模式成型三个阶段，国际上已形成风险评分、筛查工具与优先排序模式等代表性成果；国内虽有地方性规范与专科共识陆续出台，但仍缺少统一标准与实施规范。现有分级依据多停留在“维度与条目”层面，仅少数工具给出可操作的判定阈值与条目权重；效果评价涉及临床价值维度、经济价值维度、人文价值维度和过程与实施质量维度。分级工具的实际执行一致性不佳，提示后续研究重点应转向已有工具的验证、校准与规范化应用。

Abstract

Population aging and increasingly complex medication regimens have diversified the demand for pharmaceutical care， yet limited pharmaceutical resources cannot fully satisfy such clinical needs. Graded pharmaceutical care responds by stratifying patients according to risk and allocating pharmaceutical resources differentially. This review systematically summarizes the development history and current practice of graded pharmaceutical care， analyzes the development challenges and puts forward relevant suggestions. The results showed that graded pharmaceutical care has evolved through three stages： conceptual groundwork， tool development， and model consolidation. Internationally， a range of instruments has been established， including risk scoring systems， screening tools， and patient prioritization frameworks. In China， although local standards and specialty consensus statements have been issued， unified standards and implementation specifications are still lacking. Current grading criteria largely remain at the level of “dimensions and items”， with only a few tools providing operational thresholds and item weights. Outcome evaluation encompasses four dimensions： clinical value， economic value， humanistic value， and process and implementation quality value. Notably， the real-world consistency of these tools is poor. These findings suggest that the next stage should focus on validating， calibrating， and standardizing the use of existing tools.

关键词

Keywords

references

Blackburn D F ， Yakiwchuk E M ， Jorgenson D J ， et al . Proposing a redefinition of pharmaceutical care [J ] . Ann Pharmacother ， 2012 ， 46 （ 3 ）： 447 - 449 .

Żuk A ， Machuca M . Pharmaceutical care services in community pharmacies：an umbrella review of global evidence with insights from Polish and Spanish practices [J ] . Integr Pharm Res Pract ， 2025 ， 14 ： 113 - 136 .

Lee E H ， Park J O ， Cho J P ， et al . Prioritising risk factors for prescription drug overdose among older adults in South Korea：a multi-method study [J ] . Int J Environ Res Public Health ， 2021 ， 18 （ 11 ）： 5948 .

Roten I ， Marty S ， Beney J . Electronic screening of medical records to detect inpatients at risk of drug-related problems [J ] . Pharm World Sci ， 2010 ， 32 （ 1 ）： 103 - 107 .

Falconer N ， Nand S ， Liow D ， et al . Development of an electronic patient prioritization tool for clinical pharmacist interventions [J ] . Am J Health Syst Pharm ， 2014 ， 71 （ 4 ）： 311 - 320 .

Saedder E A ， Lisby M ， Nielsen L P ， et al . Detection of patients at high risk of medication errors：development and validation of an algorithm [J ] . Basic Clin Pharma Tox ， 2016 ， 118 （ 2 ）： 143 - 149 .

Hickson R P ， Steinke D T ， Skitterall C ， et al . Evaluation of a pharmaceutical assessment screening tool to measure patient acuity and prioritise pharmaceutical care in a UK hospital [J ] . Eur J Hosp Pharm ， 2017 ， 24 （ 2 ）： 74 - 79 .

Morillo-Verdugo R ， Aguilar Pérez T ， Gimeno-Gracia M ， et al . Simplification and multidimensional adaptation of the stratification tool for pharmaceutical care in people living with HIV [J ] . Ann Pharmacother ， 2023 ， 57 （ 2 ）： 163 - 174 .

Ryan M ， Dunsdon J ， Winckel K ， et al . Evaluating the effectiveness of risk categories for prioritising patients for best possible medication history completion at a quaternary hospital [J ] . Hosp Pharm ， 2026 ， 61 （ 1 ）： 81 - 88 .

卜一珊，徐彦贵，陈凡，等 . 分级药学监护制定与实施的探讨 [J ] . 中国医院药学杂志， 2015 ， 35 （ 24 ）： 2163 - 2165 .

徐萍，唐甜甜，周艳钢，等 . 医疗机构住院患者临床药学巡诊服务规范：试行 [J ] . 中南药学， 2024 ， 22 （ 1 ）： 1 - 5 .

Chen Y ， Ma X ， Lin M ， et al . Stratification system for pharmaceutical care in cancer patients：Chinese expert consensus [J ] . Front Pharmacol ， 2025 ， 16 ： 1707229 .

Caso-González A ， Núñez-Rodríguez J ， González-Pérez Y ， et al . Effectiveness on adherence to biological drugs and experience of a pharmaceutical intervention based on CMO model in patients with rheumatic disease：AdhER-2 study [J ] . An Sist Sanit Navar ， 2022 ， 45 （ 2 ）： e1004 .

Alshaikhmubarak F Q ， Keers R N ， Brown P ， et al . Explo- ring current approaches towards patient prioritisation for clinical pharmacy services in UK mental health inpatient care [J ] . BMC Psychiatry ， 2025 ， 25 （ 1 ）： 617 .

Doherty C ， Campbell G ， French O ， et al . A pharmacist-led，digital health informatics-based，insight-led care approach to aid clinical prioritization of people with diabetes and heart failure [J ] . Can Pharm J ， 2024 ， 157 （ 6 ）： 286 - 289 .

蒋欢欢，张倩影，黄炎，等 . 泌尿外科围术期患者实施标准化分级药学监护的效果评价 [J ] . 中国医院药学杂志， 2023 ， 43 （ 22 ）： 2551 - 2557 .

方圆，陈楠，葛春丽，等 . 多学科药师团队对普外科复杂消化道手术患者分级药学监护的效果评价 [J ] . 医药导报， 2022 ， 41 （ 10 ）： 1460 - 1463 .

Bernardez B ， Mangues-Bafalluy I ， Callejo V M ， et al . Risk stratification model for the pharmaceutical care of oncology patients with solid or hematologic neoplasms [J ] . Farm Hosp ， 2024 ， 48 （ 3 ）： 108 - 115 .

Abuzour A S ， Hoad-Reddick G ， Shahid M ， et al . Patient prioritisation for hospital pharmacy services：current approaches in the UK [J ] . Eur J Hosp Pharm ， 2021 ， 28 （ Suppl. 2 ）： e102 - e108 .

Valeanu A ， Damian C ， Marineci C D ， et al . The development of a scoring and ranking strategy for a patient-tailored adverse drug reaction prediction in polypharmacy [J ] . Sci Rep ， 2020 ， 10 （ 1 ）： 9552 .

Kabue S ， Liu V ， Dyer W ， et al . Identifying common predictors of multiple adverse outcomes among elderly adults with type-2 diabetes [J ] . Med Care ， 2019 ， 57 （ 9 ）： 702 - 709 .

Wu L Y ， Lv Z Y ， Chen M ， et al . Practice guidelines for the value evaluation of clinical pharmacy services：version 2 [J ] . Front Public Health ， 2024 ， 12 ： 1472355 .

Falconer N ， Liow D ， Zeng I ， et al . Validation of the assessment of risk tool：patient prioritisation technology for clinical pharmacist interventions [J ] . Eur J Hosp Pharm ， 2017 ， 24 （ 6 ）： 320 - 326 .

Korup S G ， Almarsdóttir A B ， Magnussen L . Comparison of prioritisation algorithms for the selection of patients for medication reviews in the emergency department：a cross-sectional study [J ] . Int J Clin Pharm ， 2023 ， 45 （ 4 ）： 884 - 892 .

Geurts M M ， Stewart R E ， Brouwers J R ， et al . Implications of a clinical medication review and a pharmaceutical care plan of polypharmacy patients with a cardiovascular disorder [J ] . Int J Clin Pharm ， 2016 ， 38 （ 4 ）： 808 - 815 .

Sánchez-Yáñez E ， Huertas-Fernández M J ， Robustillo-Cortes M A ， et al . Application of CMO （capacity，motivation，and opportunity） methodology in pharmaceutical care to optimize the pharmacotherapy in older people living with HIV. DISPIMDINAC project [J ] . Rev Esp Quimioter ， 2023 ， 36 （ 6 ）： 584 - 591 .

Patel M ， Chahal J K ， Robson J ， et al . Integration of a specialist pharmacist-led multidisciplinary team in primary care：preventing strokes in people with atrial fibrillation across North East London [J ] . BMJ Open Qual ， 2025 ， 14 （ 1 ）： e002804 .

Gong Y H ， Wei W ， Zhang W ， et al . Implementation effect of a hierarchical pharmaceutical service pattern in patients with systemic lupus erythematosus [J ] . J Int Med Res ， 2023 ， 51 （ 2 ）： 3000605231154749 .

孙艳，韩宁蕙 . 癫痫患儿分级药学监护路径的建立与效果评价 [J ] . 中国药物与临床， 2025 ， 25 （ 7 ）： 440 - 446 .

Guzmán Ramos M I ， Manzano Garcia M ， Robustillo-Cortés M A ， et al . Influence of CMO pharmaceutical care model-based intervention on readmission rate in high risk HIV patients：the INFARDAR study [J ] . Rev Esp Quimioter ， 2021 ， 34 （ 5 ）： 459 - 467 .

Morillo-Verdugo R ， Lazaro-Lopez A ， Alonso-Grandes E ， et al . Patient experience evaluation of the CMO-based pharmaceutical care model vs usual care in people living with HIV [J ] . J Multidiscip Healthc ， 2022 ， 15 ： 2991 - 3003 .

McIntyre F B ， Vickers L ， Wallem A ， et al . Practising prioritisation：exploring variation in applying a clinical pharmacy risk stratification tool [J ] . Eur J Hosp Pharm ， 2024 ， 31 （ 3 ）： 267 - 273 .

Falanga-Duchesneau J ， Plante G ， Racicot J ， et al . Description of pharmacist interventions based on pharmaceutical care and a vulnerability scoring tool in a tertiary care centre [J ] . Can J Hosp Pharm ， 2025 ， 78 （ 4 ）： e3687 .

Robert L ， Cuvelier E ， Rousselière C ， et al . Detection of drug-related problems through a clinical decision support system used by a clinical pharmacy team [J ] . Healthcare （Basel）， 2023 ， 11 （ 6 ）： 827 .

Cantillana-Suárez M G ， Robustillo-Cortés M L A ， Gutiérrez-Pizarraya A ， et al . Impact and acceptance of pharmacist-led interventions during HIV care in a third-level hospital in Spain using the Capacity-Motivation-Opportunity pharmaceutical care model：the IRAFE study [J ] . Eur J Hosp Pharm ， 2021 ， 28 （ Suppl. 2 ）： e157 - e163 .

Mills P ， MacLure K . A pilot study to identify elderly patients with cognitive impairment for clinical pharmacist polypharmacy review in general practice [J ] . Explor Res Clin Soc Pharm ， 2021 ， 3 ： 100065 .

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

我院人血白蛋白临床合理使用评价标准的建立与应用

Establishment and Application of Rationality Evaluation Criteria for Tumor Nutritional Standardized Treatment

Research progress on the intervention of sarcopenia with traditional Chinese medicine based on the AMPK signaling pathway

Study on the influencing factors of venetoclax trough concentration and its association with efficacy in patients with acute myeloid leukemia

Evidence-based expert consensus on the clinical application and pharmaceutical management of antibody-based drugs for the treatment of myasthenia gravis

Related Author

WANG Aming

QI Wang

WEI Xiao

QI Feng

WANG Hongxia

BIAN Hailin

WU Hui

ZHANG Ting

Related Institution

No data

⁰